Vitrectomy for Macular Hole with Macular Foveoschisis in Myopic Tractional Maculopathy PPV for MH-MFS

Case Series

J Ophthalmol & Vis Sci. 2023; 8(1): 1076.

Vitrectomy for Macular Hole with Macular Foveoschisis in Myopic Tractional Maculopathy PPV for MH-MFS

Rodríguez-Vargas G1,2*, Ortiz-Coto F1,2, Burés-Jelstrup A¹ and Mateo C¹

¹IMO – Instituto de Microcirugía Ocular, Barcelona, Spain

²UCR – Universidad de Costa Rica, San José, Costa Rica

*Corresponding author: Rodríguez-Vargas GGabriel Rodríguez-Vargas, Edificio Dualoft, Apt 29, San José, Costa Rica

Received: January 13, 2023; Accepted: February 16, 2023; Published: February 23, 2023

Abstract

Background: Macular Hole with Macular Foveoschisis (MH-MFS) represents one of the end stages of Myopic Traction Maculopathy (MTM). This study demonstrates the effectiveness of Pars Plana Vitrectomy (PPV) with appropriate Internal Limiting Membrane (ILM) peeling and use of an ILM flap without the conventional use of macular buckle for resolving this condition.

Methods: Twelve highly myopic eyes with MH-MFS underwent PPV in a single institution. Careful fovea sparing Inner Limiting Membrane (ILM) peeling with inverted flap under repeated re-staining with brilliant blue was performed. Best Corrected Visual Acuity (BCVA) and rate of Macular Hole (MH) closure, as measured by Optic Coherence Tomography.

Results: Primary MH closure was obtained in 90.9% of the cases. Best Corrected Visual Acuity (BCVA) improved in 9 patients (75%) from a baseline BCVA of 0.59 ± 0.26 log MAR (20/77) to a post-operatory BCVA of 0.35 ± 0.25 log MAR (20/44) with statistical significance (p=0.004). Foveoschisis resolution occurred as follows: 6 cases within the first month, and 9 cases by the first year. Partial resolution was achieved in 2 cases, while one failed to resolve during follow-up.

Conclusions: PPV with ILM peeling and inverted flap is a safe and effective method for managing MH-MFS. Careful identification of ILM and a thorough understanding of the vitreomacular interface abnormalities is key to surgical success.

Keywords: Myopic Foveoschisis, Macular Hole with Maculoschisis, Myopic Traction Maculopathy

Background

High myopic patients have been described to be at high risk for developing Macular Holes (MH). This entity has been reported to be the most frequent cause for MH formation in patients younger than 50 years [1]. A subtype of MH, called Macular Hole with Macular Foveoschisis (MH-MFS) is characterized by the presence of retinoschisis secondary to a posterior staphyloma in highly myopic patients [2-4].

Myopic Tractional Maculopathy (MTM) is a term coined by Panozzo G. in 2014 to describe the spectrum of tractional foveal changes in highly myopic eyes [5]. These changes are caused by a progressive enlargement and elongation of the sclera, resulting in stretching of the choroidal-retinal pigmented epithelium-retina complex in two directions, both perpendicular and/or tangential to the retina [6]. MH-MFS represents one of the end stages of MTM and is associated with worse prognosis, both functional and anatomical [7,8].

Pars Plana Vitrectomy (PPV) was proposed as treatment for this entity, but initial results analyzed up to 2012 were discouraging [9,10]. Aiming to improve MH-MFS closure rates, Macular Buckling (MB) together with PPV was employed to counteract the tractional effect induced by the posterior staphyloma, showing excellent MH-MFS closure rates and halting progression towards a retinal detachment, but represents a highly complex procedure [11-14].

Recent studies show that the inverted Internal Limiting Membrane (ILM) flap technique, described in 2010 for MH [15], is highly efficient in closing MH in highly myopic patients without foveoschisis [15,16], and in patients with Macular Hole Retinal Detachment (MHRD) [15,17]. However, the cases of MH-MFS remain to be evaluated under this technique.

New findings in highly myopic eyes with retinoschisis, using enhanced vitreous imaging with Optical Coherence Tomography (OCT), immunocytochemistry and transmission electron microscopy, reveal a high prevalence of Vitreo Macular Interface (VMI) abnormalities, where the vitreous cortex tends to remain attached thus creating traction to the foveal area even in eyes with complete Posterior Vitreous Detachment (PVD) [14,18].

In this retrospective study, we re-evaluate PPV on the hypothesis that removing the VMI abnormalities and using the inverted ILM flap technique MH-MFS is a safe and efficient technique without the surgical complications associated with a MB.

Methods

This retrospective observational study was conducted, main inclusion criteria was the presence of MH-MFS documented by OCT. High myopia was considered as an axial length of >26.5 mm, full-thickness MH was defined as a foveal break of all cellular retinal layers (connecting VMI abnormalities were not considered to define the presence of a MH) and foveoschisis as an enlargement of the retinal thickness due to separation of the neurosensory retina in two or more layers.

Exclusion criteria included: lamellar MH-MFS (cases in which outer retinal layers were detected within the area of the hole), MHRD (defined by us as a neurosensorial retinal detachment of more than 3000 μm with a base to hole ratio >10:1), previous retinal surgery and severe optic nerve changes.

Surgical Procedure

All patients underwent standard 3-port 23-gauge PPV performed by the same surgeon (C.M.). ILM staining was performed with Brilliant Blue, 0.025% (Tissue blue; DORC International, Netherlands). Visualization of the macular area was achieved using macular contact lens (Macular Window; Advanced Visual Instruments, New York). Pre-ILM material (or VMI abnormalities) were removed using an ILM forceps in a circular manner. After this, if needed, repeated staining was conducted until a homogeneous staining was obtained, followed by the grasping and peeling of the ILM in a circular manner for approximately two-disc diameters around the MH with the use of ILM forceps. An inverted foveal-sparing trimmed flap of ILM attached to the periphery was placed over the macular hole. This step was performed under liquid perfluorocarbon (PFCL) to maintain stability of the flap. A drop of platelet concentrate was used as adhesive substance to maintain the flap in place. Fluid-air exchange was then performed and finally, a sulfur hexafluoride (SF6) tamponade was used. Patients were advised to maintain a prone position for 5 days.

Evaluation

All patients were examined before macular surgery and had a minimum of 6 months follow up after surgery. At each visit, patients underwent a complete ophthalmologic examination, including refraction, Best-Corrected Visual Acuity (BCVA) using Early Treatment Diabetic Retinal Study (ETDRS) chart, fundus photography with a mydriatic fundus camera (TRC-50X type IA; Topcon, Tokyo, Japan), measurement of axial length by optical biometry (IOL Master 500; Carl Zeiss Meditec AG, Jane, Germany), and spectral-domain OCT (SD-OCT) using the Cirrus HD-OCT 5000 system (software version 11.5.1) (Carl Zeiss Meditec, Dublin, CA).

The primary outcome was anatomic macular hole closure with resolution of the foveoschisis, defined as the resolution of the full thickness neurosensory defect over the fovea and at least a 50% decrease in retinal thickness in the central horizontal 6mm HD Line Raster. Secondary outcomes were changes in BCVA, preoperative Hole Form Factor (HFF) and time for foveoschisis resolution.

Statistical Analysis

Numerical variables were analyzed using paired t-student test. Qualitative variables are expressed as frequencies and percentages and were analyzed using chi-square test. Associations between the final BCVA and the clinical parameters were examined by univariate analysis. Statistical analysis was performed in R (version 4.0.3; R Core Team, Vienna, Austria) using a p-value <0.05 for statistical significance

Results

Results from 12 eyes of 12 consecutive patients (9 female, 3 male) were analyzed. Their mean age was 59.3 ± 11.4 years (range: 44-77 years). The mean Axial Length (AL) was 32.2 mm (range: 27.7-35.2 mm). 8 eyes were pseudo phakic, none were aphakic and cataract surgery was performed simultaneously with PPV in one patient. Postoperative follow upranged between 6 to 52 months with a median period of 17 months. ILM peeling was performed in all cases, while successful foveal-sparing ILM flap was obtained in 10 (83.3%) cases. No choroidal detachments or intraocular hemorrhages were reported intra or postoperative.

Closure of MH at the first month follow-up visit was achieved in 11 (90.9%) patients. All these cases remained closed during the follow up. One case failed to close by the first month and was re intervened. The ability to create or not a foveal sparring ILM-flap didn’t influence the MH-closure rate or the resolution of the foveoschisis.

Foveoschisis resolved completely in 9 (75%) patients, resolved partially in 2 (16,7%) patients, and persisted in 1 (8,3%) patient. In those patients in which foveoschisis resolved completely, resolution was seen by the first month in half of patients while the remaining 25% resolved within the first year. Partial resolution or non-resolution of foveoschisis was not associated with a worse visual outcome.

Main BCVA improved from 0.59 ± 0.26 logMAR (Snellen 20/77) preoperatively to 0.35 ± 0.25 log MAR (Snellen 20/44) with statistical significance (p=0.004). BCVA improved postoperatively in 9 patients (75%), two remained unchanged and worsened in one patient. None of the preoperative characteristics of the MH-MFS (Table 2) were found to correlate with the visual or anatomical success.